Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19

BACKGROUND: Haemodialysis patients are extremely vulnerable to COVID-19. Their immune response after infection is unclear. We have found high seroconversion rates in this population with 95% developing antibodies. It is unclear if and how long these antibodies persist. Here we investigate this with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nephrol Dial Transplant
Main Authors: Forbes, Suzanne, Davari, Maria, Gnanasampanthan, Sahana, Roth, Noam, Young, Gregor, Rajakariar, Ravindra, Cove-Smith, Andrea, Yaqoob, Muhammed Magdi, Cutino-Moguel, Teresa, Mahalingasivam, Viyaasan, McCafferty, Kieran
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Original Article - Dialysis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7989221/
https://ncbi.nlm.nih.gov/pubmed/33720379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfab066
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares